Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,500 | 64,100 | 64,800 | 104,073 | 86,352 |
| Marketable Securities | 90,500 | 80,700 | 121,600 | 268,243 | 254,180 |
| Receivables | 95,000 | 87,700 | 85,100 | 96,978 | 63,101 |
| Inventories | 38,300 | 25,100 | 23,900 | 5,007 | 11,574 |
| Income taxes - deferred | N/A | 13,500 | 6,500 | 8,007 | 5,572 |
| TOTAL | $314,500 | $283,600 | $322,400 | $483,992 | $422,492 |
| Non-Current Assets | |||||
| PPE Net | 58,300 | 67,200 | 34,600 | 27,602 | 24,231 |
| Investments And Advances | 79,900 | 40,600 | 84,100 | 158,748 | 113,692 |
| Intangibles | 422,800 | 369,800 | 374,500 | 70,180 | 72,572 |
| Other Non-Current Assets | 5,000 | 5,000 | 8,200 | 63,299 | 57,648 |
| TOTAL | $566,000 | $482,600 | $501,400 | $319,829 | $268,143 |
| Total Assets | $880,500 | $766,200 | $823,800 | $803,821 | $690,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,100 | 21,100 | 23,100 | 18,132 | 10,141 |
| Accrued Expenses | 49,500 | 46,100 | 56,400 | 44,334 | 32,772 |
| TOTAL | $72,300 | $68,700 | $80,600 | $64,509 | $44,967 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,700 | 1,500 | 1,100 | 2,043 | 2,054 |
| Other Non-Current Liabilities | 42,200 | 35,200 | 24,200 | 10,718 | 10,008 |
| TOTAL | $60,100 | $35,400 | $24,200 | $10,718 | $10,008 |
| Total Liabilities | $132,400 | $104,100 | $104,800 | $75,227 | $54,975 |
| Shareholders' Equity | |||||
| Common Shares | 700 | 700 | 700 | 806 | 826 |
| Retained earnings | -73,200 | -77,000 | 2,000 | 30,866 | -12,684 |
| Other shareholders' equity | -9,500 | -7,000 | -1,500 | -424 | -162 |
| TOTAL | $748,100 | $662,100 | $719,000 | $728,594 | $635,660 |
| Total Liabilities And Equity | $880,500 | $766,200 | $823,800 | $803,821 | $690,635 |